Customers frequently ask whether a package that arrived warm has been ruined. For lyophilised peptides the answer is usually no — and the reasoning is worth understanding, because it also identifies the conditions that genuinely do cause problems.
Dry peptide is considerably more robust in transit than its long-term storage recommendations suggest. Those recommendations exist to preserve material over years, not days.
Storage conditions and transit conditions are different questions
A vial labelled “store at −20 °C” is telling you the condition that maximises stability over an extended period. It is not stating that the material fails above that temperature.
Lyophilised peptides are routinely shipped at ambient temperature by suppliers worldwide. The material tolerates days at room temperature — and often substantially higher — with degradation that is measurable in a laboratory but negligible in practical terms.
The relevant distinction:
| Timeframe | Governing factor |
|---|---|
| Days (transit) | Peak temperature and moisture exposure |
| Months to years (storage) | Sustained temperature, humidity, light |
Degradation follows Arrhenius kinetics — rate increases roughly exponentially with temperature — but the absolute amount of degradation depends on rate multiplied by time. A few days at 30 °C represents a small fraction of the degradation that a year at 4 °C would produce.
What actually causes transit damage
Moisture ingress is the most consequential risk, not heat. A compromised stopper or seal admits humid air, and lyophilised material absorbs it rapidly. Once moisture is present, hydrolysis and deamidation begin, and they continue regardless of what the temperature does afterwards.
Sustained high temperature matters more than a brief peak. A package left on a delivery vehicle in summer for several hours is a different situation from one sitting in a hot warehouse for a week.
Freeze–thaw cycling is irrelevant for dry material. This is the one people most often get backwards. Freeze–thaw damage is a solution-phase phenomenon — it’s caused by ice crystal formation and solute concentration at the freezing front. Lyophilised powder has no meaningful free water, so cycling between temperatures does not produce that damage. It matters enormously after reconstitution and not at all before.
Physical damage — a cracked vial or dislodged stopper — is straightforwardly disqualifying and easy to check.
Light exposure is minor over transit timeframes but real for photosensitive sequences containing tryptophan, tyrosine, phenylalanine, methionine or cysteine. Opaque outer packaging addresses it.
When cold chain genuinely matters
Cold shipping is warranted for:
- Peptides supplied in solution — these have no dry-state protection and degrade on the timescale their storage conditions imply
- Particularly labile sequences, especially those with multiple oxidation- prone residues
- Long transit times, where days become weeks through customs or remote delivery
- Extreme ambient conditions, where sustained exposure well above 30 °C is likely
For standard lyophilised material moving within a few days, ambient shipping with appropriate packaging is the accepted approach across the industry.
What appropriate packaging looks like
A sealed moisture barrier. The single most important element, since moisture is the primary transit risk. Vials should be sealed against humid air, and a desiccant pack in the package is a good sign.
Opaque outer packaging, which addresses light exposure and is standard anyway.
Physical protection. Glass vials need cushioning that survives normal courier handling.
Insulation or cold packs where warranted, based on the destination and the material — not as a default gesture. A gel pack that has fully thawed by delivery has provided a few hours of buffering, which is generally enough.
Inspecting material on arrival
Worth doing on receipt rather than at first use, when a supplier conversation is still straightforward.
1. Check the vial physically. Cracks, chips, a dislodged or partially raised stopper, or any sign the seal has been compromised.
2. Look at the cake. Compare against the appearance stated on the certificate of analysis. A cracked or shrunken cake is cosmetic. Material that is visibly damp, sticky, discoloured, or has collapsed into a glassy mass is worth querying.
3. Confirm the lot number on the vial matches the certificate you’ve been given. A certificate for a different batch tells you nothing about your material.
4. Note whether vacuum was present when you first pierce the stopper. An audible inrush suggests the seal held.
5. Get it into proper storage. Once inspected, dry and cold at the earliest opportunity. Total cumulative time at ambient is what matters, and transit has already used some of it.
If a package arrives warm
For dry lyophilised material, a warm package is not by itself a reason to discard it.
Reasonable steps:
- Inspect as above, with attention to seal integrity and cake appearance
- Move it into cold storage promptly
- Where the work is sensitive, verify by whatever analytical method you have available — analysis beats speculation
- Contact the supplier if anything about the vial or cake looks wrong
What isn’t reasonable is assuming the material is fine because it looks fine, or assuming it’s ruined because the box was warm. Appearance is a weak indicator in both directions, which is why the seal and the cake structure are what to examine.
Storage once received
Transit is a small fraction of a peptide’s life. The conditions it lives under afterwards matter far more:
| Condition | Practical storage life |
|---|---|
| −80 °C, desiccated, dark | Longest — archival |
| −20 °C, desiccated, dark | Years for most sequences |
| 4 °C, desiccated | Months |
| Room temperature | Weeks |
Our shipping and returns page covers transit times and packaging for metabolic research compounds and the rest of the catalog.
Reconstituted material is a different regime entirely and should be aliquoted before freezing. That’s covered in detail in the reconstitution guide below.
References
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 2010;27(4):544–575. doi:10.1007/s11095-009-0045-6
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics, 2000;203(1–2):1–60. doi:10.1016/S0378-5173(00)00423-3
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JH, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. Journal of Pharmaceutical Sciences, 2012;101(3):895–913. doi:10.1002/jps.22812
- Reubsaet JL, Beijnen JH, Bult A, van Maanen RJ, Marchal JA, Underberg WJ. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. Journal of Pharmaceutical and Biomedical Analysis, 1998;17(6–7):955–978. doi:10.1016/S0731-7085(98)00063-6
Related reading
- Reconstituting and storing lyophilised peptides
- Lyophilisation: why research peptides ship as powder
- Common handling errors that compromise sample integrity
All VANTA products are supplied for laboratory research use only. They are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.